Andrew Goldsweig to Blood Transfusion
This is a "connection" page, showing publications Andrew Goldsweig has written about Blood Transfusion.
Connection Strength
0.748
-
Simon T, Herbert BM, Brooks MM, Goodman SG, Alexander JH, Steg PG, Lopes RD, Ghafghazi S, Bouleti C, Cooper HA, McCamant EL, Bainey KR, Aronow HD, Abbott JD, Alsweiler C, Bertolet M, Fergusson DA, Goldsweig AM, H?bert PC, Carson JL. Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial. Circulation. 2024 Sep 24; 150(13):1064-1066.
Score: 0.219
-
DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR, White HD, Goldsweig AM, Polonsky TS, Gupta R, Alsweiler C, Silvain J, de Barros E Silva PGM, Hillis GS, Daneault B, Tessalee M, Menegus MA, Rao SV, Lopes RD, H?bert PC, Alexander JH, Brooks MM, Carson JL, Goodman SG. Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024 Dec 03; 150(23):1826-1836.
Score: 0.218
-
Carson JL, Brooks MM, H?bert PC, Goodman SG, Bertolet M, Glynn SA, Chaitman BR, Simon T, Lopes RD, Goldsweig AM, DeFilippis AP, Abbott JD, Potter BJ, Carrier FM, Rao SV, Cooper HA, Ghafghazi S, Fergusson DA, Kostis WJ, Noveck H, Kim S, Tessalee M, Ducrocq G, de Barros E Silva PGM, Triulzi DJ, Alsweiler C, Menegus MA, Neary JD, Uhl L, Strom JB, Fordyce CB, Ferrari E, Silvain J, Wood FO, Daneault B, Polonsky TS, Senaratne M, Puymirat E, Bouleti C, Lattuca B, White HD, Kelsey SF, Steg PG, Alexander JH. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. N Engl J Med. 2023 Dec 28; 389(26):2446-2456.
Score: 0.207
-
Carson JL, Fergusson DA, Noveck H, Mallick R, Simon T, Rao SV, Cooper H, Stanworth SJ, Portela GT, Ducrocq G, Bertolet M, DeFilippis AP, Goldsweig AM, Kim S, Triulzi DJ, Menegus MA, Abbott JD, Lopes RD, Brooks MM, Alexander JH, H?bert PC, Goodman SG, Steg PG. Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis. NEJM Evid. 2025 Feb; 4(2):EVIDoa2400223.
Score: 0.056
-
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, H?bert PC. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023 03; 257:120-129.
Score: 0.048